Acquired Company
Nestlé completed acquisition of Aimmune Therapeutics, Inc. (Nasdaq: AIMT) on October 14, 2020.
Show more
Location: | Industry: | Sector:
Market Cap
0.00
52 Wk Range
$N/A - $N/A
Previous Close
$34.49
Open
$34.49
Volume
N/A
Day Range
$34.49 - $34.49
Enterprise Value
0.00
Cash
0.00
Avg Qtr Burn
N/A
Insider Ownership
0.00%
Institutional Own.
0.00%
Qtr Updated
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
AR201 Details Allergy | Phase 2 Data readout |
